3,5-Diiodo-l-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Recent reports demonstrated that 3,5-diiodo-l-thyronine (T 2) was able to prevent lipid accumulation in the liver of rats fed a high-fat diet (HFD). In this study, we investigated how the rat liver responds to HFD and T 2 treatment by assessing the transcription profiles of some genes involved in the pathways of lipid metabolism: oxidation, storage and secretion. The mRNA levels of the peroxisome proliferator-activated receptors (PPARα, PPARγ and PPARδ), and of their target enzymes acyl-CoA oxidase and stearoyl-CoA desaturase were evaluated by real-time RT-PCR. Moreover, the expression of the adipose triglyceride lipase involved in lipid mobilisation, of the main PAT proteins acting in lipid droplet (LD) turnover, and of apoprotein B (apo B), the major protein component of very low-density lipoproteins (VLDLs) were analysed. Overall, our data demonstrated that T 2 administration to HFD rats counteracts most of the hepatic transcriptional changes that occurred in response to the excess exogenous fat. In particular, our results suggest that T 2 may prevent the pathways leading to lipid storage in LDs, promote the processes of lipid mobilisation from LDs and secretion as VLDL, in addition to the stimulation of pathways of lipid oxidation. In conclusion, our findings might give an insight into the mechanisms underlying the anti-steatotic ability of T 2 and help to define the potential therapeutic role of T 2 for preventing or treating liver steatosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772 · cited 1×
“This can be explained by the role of PPARa in stimulating the activities of the FFA oxidation systems (Duval et al. 2007, Pyper et al. 2010) and of PPARg in promoting fat accumulation in LDs (Gavrilova et al. 2003, Browning & Horton 2004).”
BackgroundDefective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., Heldmaier, G., Maier, R., Theussl, C., Eder, S., et al. (2006) · Science · doi:10.1126/science.1123965 · Cited by 1,375 · cited 1×
“ATGL is considered the ratelimiting lipolytic enzyme in mammals (Haemmerle et al. 2006), and is a major TAG lipase in the liver where it acts, likely through PPARa, to channel hydrolyzed FFAs towards oxidative pathways as opposed to VLDL secretory pathways (Ong et al. 2011).”
BackgroundSchoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173
Regulation of Lipolysis in Adipocytes
Duncan, R. E., Ahmadian, M., Jaworski, K., Sarkadi-Nagy, E., & Sul, H. S. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093734 · Cited by 1,021 · cited 1×
“Recently, discovered adipose triglyceride lipase (ATGL) selectively performs the first step in TAG hydrolysis (Duncan et al. 2007, Zechner et al. 2009), and is constitutively expressed in the liver of mammals (Reid et al. 2008).”
BackgroundPeroxisome proliferator-activated receptors in inflammation control
Delerive, P., Fruchart, J., & Staels, B. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690453 · Cited by 755 · cited 1×
“…but it promotes lipid accumulation also in hepatocytes where it plays anti-inflammatory effects by both reducing inflammatory cytokine and chemokine expression and preventing the activation of pro-inflammatory transcription factors (Delerive et al. 2001, Straus & Glass 2007, Kapadia et al. 2008).”
BackgroundAdipose triglyceride lipase and the lipolytic catabolism of cellular fat stores.
Zechner, R., Kienesberger, P. C., Haemmerle, G., Zimmermann, R., & Lass, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800031-jlr200 · Cited by 576
Pioglitazone Induces Mitochondrial Biogenesis in Human Subcutaneous Adipose Tissue In Vivo
Bogacka, I., Xie, H., Bray, G. A., & Smith, S. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1392 · Cited by 467
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Kapadia, R. (2008) · Frontiers in Bioscience · doi:10.2741/2802 · Cited by 433
Evolutionarily conserved gene family important for fat storage
Kadereit, B., Kumar, P., Wang, W.-J., Miranda, D., Snapp, E. L., Severina, N., Torregroza, I., Evans, T., & Silver, D. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708579105 · Cited by 252 · cited 2×
“…with the endoplasmic reticulum (ER) DOI: 10.1530/JOE-11-0288 Britain Online version via http://www.endocrinology-journals.org Downloaded from Bioscientifica.com at 03/10/2022 01:31:55AM via free access resident protein fat-inducing transcript 2 (FIT2; Kadereit et al. 2008, Sun et al. 2010).”
BackgroundMethodInfluentialDUVAL, C., MULLER, M., & KERSTEN, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.05.003 · Cited by 199 · cited 1×
“This can be explained by the role of PPARa in stimulating the activities of the FFA oxidation systems (Duval et al. 2007, Pyper et al. 2010) and of PPARg in promoting fat accumulation in LDs (Gavrilova et al. 2003, Browning & Horton 2004).”
Background
Cited by
Sinha, R. A., Bruinstroop, E., Singh, B. K., & Yen, P. M. (2019) · Thyroid · doi:10.1089/thy.2018.0664 · Cited by 271
Lehmphul, I., Brabant, G., Wallaschofski, H., Ruchala, M., Strasburger, C. J., Köhrle, J., & Wu, Z. (2014) · Thyroid® · doi:10.1089/thy.2013.0688 · Cited by 58
“…loss of body fat by increasing energy expenditure (10,11) prevents insulin resistance (12,13), and exerts remarkably rapid anti-steatotic (14–16) and metabolic actions (11,17) upon administration of pharmacological doses in mainly hypothyroid rodent models, two human volunteers (3), and…”
3,5-T2 alters murine genes relevant for xenobiotic, steroid, and thyroid hormone metabolism
Lietzow, J., Golchert, J., Homuth, G., Völker, U., Jonas, W., & Köhrle, J. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0159 · Cited by 28
Pietzner, M., Köhrle, J., Lehmphul, I., Budde, K., Kastenmüller, G., Brabant, G., Völzke, H., Artati, A., Adamski, J., Völker, U., et al. (2019) · Thyroid® · doi:10.1089/thy.2018.0549 · Cited by 13
Metadata
- Authors
- Grasselli, E., Voci, A., Demori, I., Canesi, L., De Matteis, R., Goglia, F., Lanni, A., Gallo, G., & Vergani, L.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2011-11-22
- Volume
- 212
- Issue
- 2
- Pages
- 149-158
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2129790652
- Cited by
- 44
- References
- 14
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 3,5-Diiodo-l-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver. https://app.cochat.ai/papers/10.1530/joe-11-0288
- The paper
- Grasselli, E., Voci, A., Demori, I., Canesi, L., De Matteis, R., Goglia, F., Lanni, A., Gallo, G., & Vergani, L. (2012). 3,5-Diiodo-l-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver. Journal of Endocrinology. https://doi.org/10.1530/joe-11-0288
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.